SR ONE CAPITAL MANAGEMENT, LLC is an investment firm that reports beneficial ownership of shares in Odyssey Therapeutics, Inc. (ODTX) and 2 other companies under U.S. securities law. It has submitted 3 SEC insider filings since 2025, most recently in May 2026.
Every role SR ONE CAPITAL MANAGEMENT, LLC has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
Odyssey Therapeutics, Inc. (ODTX)1 filingAvalyn Pharma Inc. (AVLN)1 filingZenas BioPharma, Inc. (ZBIO)1 filingUpdated Aug 30, 2026
SR ONE CAPITAL MANAGEMENT, LLC files SEC Form 4 reports at Odyssey Therapeutics, Inc. (ODTX). 3 SEC Form 4 filings on record going back to 2025, most recently on 12 May 2026. Most recent open-market trade: bought $3.60M of ODTX on 12 May 2026. Lifetime open-market purchases: $22.40M. Lifetime open-market sales: $32K. Historical track record: 1/5 stars across 7 tracked purchases.
Every recent SEC Form 4 transaction SR ONE CAPITAL MANAGEMENT, LLC has reported, most recent first.
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realized performance after each tracked open-market purchase.
| Metric | Value |
|---|---|
| InsiderAlpha rating | ★☆☆☆☆ (1/5) |
| Total purchases tracked | 7 |
| Purchases with forward-return data | 7 |
| 30-day win rate | 29% |
| 90-day win rate | 43% |
| Avg 5-day return | -4.15% |
| Avg 30-day return | -1.27% |
| Avg 90-day return | -0.49% |
| Best 30-day return |
InsiderAlpha's records for SR ONE CAPITAL MANAGEMENT, LLC go back to 2025: 3 primary Form 4 filings, an average of 1.5 per year. The typical open-market purchase is $3.20M (7 buys totaling $22.40M). The largest single buy on record is $5.00M of AVLN in 2026. Sales side: 3 recorded sales totaling $32K, so the filing history runs buy-heavy by dollar value. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Insiders who reported open-market trades in the last 12 months at the companies SR ONE CAPITAL MANAGEMENT, LLC files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
SR ONE CAPITAL MANAGEMENT, LLC is an investment firm of Odyssey Therapeutics, Inc. (ODTX). InsiderAlpha holds 3 primary Form 4 filings for it, the earliest from 2025, updated as new SEC EDGAR filings are processed.
The most recent primary Form 4 on record is dated 12 May 2026, one of 3 filings going back to 2025.
Recorded transactions: 7 open-market purchases ($22.40M) and 3 open-market sales ($32K) across all tracked filings.
Across 7 tracked purchases, SR ONE CAPITAL MANAGEMENT, LLC averaged -1.3% avg 30-day return with a 29% 30-day win rate. InsiderAlpha rates the track record at 1/5 stars.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
$ODTX Odyssey Therapeutics, Inc.78.7K shares @ --
| +16.97% |